Researchers at Massachusetts Institute of Technology (MIT) and the University of Colorado at Denver in the US are working on repurposing an existing blood clots drug to help patients at risk of respiratory failure.
The drug is a tissue plasminogen activator (tPA) used to help heart attack and stroke patients. Three hospitals in Massachusetts and Colorado intend to test the drug in severely ill Covid-19 patients.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Read the full article here
